I

INIFY Laboratories AB
OSE:INIFY

Watchlist Manager
INIFY Laboratories AB
OSE:INIFY
Watchlist
Price: 3.58 NOK 2.29% Market Closed
Market Cap: kr282.5m

Net Margin

-8 682.1%
Current
Improving
by 11 527.7%
vs 3-y average of -20 209.8%

Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.

Net Margin
-8 682.1%
=
Net Income
kr-38.9m
/
Revenue
kr409k

Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.

Net Margin
-8 682.1%
=
Net Income
kr-38.9m
/
Revenue
kr409k

Peer Comparison

Country Company Market Cap Net
Margin
SE
INIFY Laboratories AB
OSE:INIFY
282.5m NOK
Loading...
US
CVS Health Corp
NYSE:CVS
90.2B USD
Loading...
US
Cigna Group
XMUN:CGN
63B EUR
Loading...
US
Cigna Corp
NYSE:CI
72.3B USD
Loading...
DE
Fresenius SE & Co KGaA
XETRA:FRE
27.6B EUR
Loading...
DE
Fresenius Medical Care AG
XMUN:FME
21.8B EUR
Loading...
US
Laboratory Corporation of America Holdings
NYSE:LH
22.3B USD
Loading...
US
Quest Diagnostics Inc
NYSE:DGX
20.4B USD
Loading...
US
Guardant Health Inc
NASDAQ:GH
14.3B USD
Loading...
DE
Fresenius Medical Care AG & Co KGaA
XETRA:FME
10.8B EUR
Loading...
AU
Sonic Healthcare Ltd
ASX:SHL
11.1B AUD
Loading...

Market Distribution

Lower than 97% of companies in Sweden
Percentile
3rd
Based on 2 084 companies
3rd percentile
-8 682.1%
Low
-5 565 412.8% — -5.3%
Typical Range
-5.3% — 7.5%
High
7.5% — 12 228%
Distribution Statistics
Sweden
Min -5 565 412.8%
30th Percentile -5.3%
Median 3%
70th Percentile 7.5%
Max 12 228%

INIFY Laboratories AB
Glance View

Market Cap
282.5m NOK
Industry
Health Care

INIFY Laboratories AB engages in the provision of cancer diagnostics through laboratory services within pathology. The company is headquartered in Stockholm, Stockholm. The company went IPO on 2022-06-20. The firm uses a fully digital, standardized and Artificial Intelligence (AI)- supported workflow to optimize quality and response times, initially within prostate. The service includes the whole chain of sample handling: from logistics, to sample preparation, to reporting by a pathologist from either Inify Laboratories or the customer’s organization. INIFY Laboratories' laboratory in Solna, Sweden is intended to provide two types of analyses of prostate Biopsy Specimens to clients: Full pathology Report signed by an INIFY subspecialized pathologist and Whole Slide Images (WSI) generation and result of Pathology Decision Support Tool (PDST) analysis only. The firm origins from ContextVision.

INIFY Intrinsic Value
0.07 NOK
Overvaluation 98%
Intrinsic Value
Price
I
What is Net Margin?
Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.
How is Net Margin calculated?

Net Margin is calculated by dividing the Net Income by the Revenue.

Net Margin
-8 682.1%
=
Net Income
kr-38.9m
/
Revenue
kr409k
What is INIFY Laboratories AB's current Net Margin?

The current Net Margin for INIFY Laboratories AB is -8 682.1%, which is above its 3-year median of -20 209.8%.

How has Net Margin changed over time?

Over the last 5 months, INIFY Laboratories AB’s Net Margin has increased from -30 660.6% to -8 682.1%. During this period, it reached a low of -30 660.6% on May 30, 2023 and a high of -9 759% on Oct 30, 2023.

Back to Top